News Hortons Pharmacy Astellas, a pharmaceutical company, disagrees with European authorities about their drug, Izervay, which is used to treat a condition called geographic atrophy. Dec 04, 2024Dec 20, 2024
News Hortons Pharmacy “5 Important FDA Decisions to Look Out for in the Last Quarter of the Year” Dec 01, 2024Dec 20, 2024
News Hortons Pharmacy After a previous unsuccessful trial, EyePoint’s drug Duravyu shows promising results in treating diabetic macular edema (DME). Dec 01, 2024Dec 20, 2024
News Hortons Pharmacy Pharmaceutical companies are quickly working to develop a new weight-loss drug similar to Wegovy. Here are some important studies on obesity treatments to keep an eye on. Nov 28, 2024Dec 20, 2024
News Hortons Pharmacy RNA editing, a technique for altering genetic information, is starting to gain attention alongside the well-known CRISPR technology. Nov 25, 2024Dec 20, 2024
News Hortons Pharmacy The UK health authority, NICE, has approved new medications from Pfizer and AstraZeneca. Nov 25, 2024Dec 20, 2024
News Hortons Pharmacy Biogen is making changes to its top management team, while Novartis is reducing the reported value of its investments in MorphoSys. Nov 22, 2024Dec 20, 2024
News Hortons Pharmacy The UAE has become more experienced and advanced in conducting clinical trials, thanks to the lessons learned from the Covid-19 pandemic. Nov 22, 2024Dec 20, 2024
News Hortons Pharmacy GSK is paying $300 million to get the rights to a drug they believe could treat lupus. Nov 19, 2024Dec 20, 2024
News Hortons Pharmacy The FDA has given special status to Modalis’ MDL-101 drug for treating LAMA2-related congenital muscular dystrophy (CMD). Nov 19, 2024Dec 20, 2024